New appointment at Amylin
This article was originally published in Scrip
Executive Summary
Amylin Pharmaceuticals (US) has named Vincent Mihalik senior vice-president of sales and marketing and chief commercial officer. Mr Mihalik brings more than 30 years' industry experience, having previously served as vice-president of global brand development diabetes and endocrine platform team leader at Lilly.